Syon Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.04M Buy
5,244
+463
+10% +$185K 0.07% 242
2026
Q2
$1.85M Buy
4,781
+512
+12% +$190K 0.08% 179
2026
Q1
$1.25M Buy
4,269
+1,835
+75% +$603K 0.06% 235
2025
Q4
$853K Sell
2,434
-11
-0.4% -$3.72K 0.04% 356
2025
Q3
$790K Sell
2,445
-1,723
-41% -$536K 0.04% 324
2025
Q2
$1.62M Sell
4,168
-10
-0.2% -$4.02K 0.11% 139
2025
Q1
$1.82M Buy
4,178
+480
+13% +$193K 0.15% 100
2024
Q4
$1.36M Buy
3,698
+49
+1% +$20.5K 0.12% 121
2024
Q3
$1.9M Buy
3,649
+13
+0.4% +$6.94K 0.17% 95
2024
Q2
$1.97M Buy
3,636
+104
+3% +$55K 0.18% 88
2024
Q1
$1.83M Buy
3,532
+313
+10% +$156K 0.17% 93
2023
Q4
$1.52M Buy
3,219
+761
+31% +$352K 0.16% 101
2023
Q3
$1.07M Buy
+2,458
New +$1.11M 0.13% 98

Other funds holding ELV

Syon Capital's ELV Position: Q3 2026 in Review

Syon Capital increased its Elevance Health (ELV) stake by 9.7% in Q3 2026, buying an estimated $185K and bringing the position to 5,244 shares worth $2.04M. The position accounts for 0.07% of the portfolio, ranked #242.

Syon Capital first reported a position in ELV in Q3 2023 and has held it in 13 quarters since. 1,615 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Syon Capital held 5,244 shares of Elevance Health worth $2.04M as of Q3 2026.
  • Syon Capital bought 463 Elevance Health shares in Q3 2026, an estimated $185K.
  • Elevance Health made up 0.07% of Syon Capital's portfolio in Q3 2026, its #242 holding.
  • Syon Capital first reported a position in Elevance Health in Q3 2023 and has held it in 13 quarters since.
  • 1,615 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.